Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pseudomonas syringae pv. tomato Probable cytosol aminopeptidase (pepA) CSB-YP803415FGP
CSB-EP803415FGP
CSB-BP803415FGP
CSB-MP803415FGP
CSB-EP803415FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Molybdenum cofactor biosynthesis protein C (moaC) CSB-YP803416FGP
CSB-EP803416FGP
CSB-BP803416FGP
CSB-MP803416FGP
CSB-EP803416FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Alginate biosynthesis protein AlgX (algX) CSB-YP803417FGP
CSB-EP803417FGP
CSB-BP803417FGP
CSB-MP803417FGP
CSB-EP803417FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Ribosomal RNA small subunit methyltransferase C (rsmC) CSB-YP803418FGP
CSB-EP803418FGP
CSB-BP803418FGP
CSB-MP803418FGP
CSB-EP803418FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tomato pseudo-curly top virus Protein C4 (C4, L4) CSB-YP803419TDAC
CSB-EP803419TDAC
CSB-BP803419TDAC
CSB-MP803419TDAC
CSB-EP803419TDAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Glutamyl-tRNA reductase (hemA) CSB-YP803420FGP
CSB-EP803420FGP
CSB-BP803420FGP
CSB-MP803420FGP
CSB-EP803420FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Ribose-phosphate pyrophosphokinase (prs) CSB-YP803421FGP
CSB-EP803421FGP
CSB-BP803421FGP
CSB-MP803421FGP
CSB-EP803421FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Sulfoxide reductase catalytic subunit YedY (yedY) CSB-YP803422FGP
CSB-EP803422FGP
CSB-BP803422FGP
CSB-MP803422FGP
CSB-EP803422FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Glucose-6-phosphate isomerase (pgi), partial CSB-YP803423FGP
CSB-EP803423FGP
CSB-BP803423FGP
CSB-MP803423FGP
CSB-EP803423FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC) CSB-YP803424WBH
CSB-EP803424WBH
CSB-BP803424WBH
CSB-MP803424WBH
CSB-EP803424WBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Chaperone protein ClpB (clpB), partial CSB-YP803425FGP
CSB-EP803425FGP
CSB-BP803425FGP
CSB-MP803425FGP
CSB-EP803425FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 50S ribosomal protein L27 (rpmA) CSB-YP803426FGP
CSB-EP803426FGP
CSB-BP803426FGP
CSB-MP803426FGP
CSB-EP803426FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Adenine deaminase (PSPTO_0757) CSB-YP803427FGP
CSB-EP803427FGP
CSB-BP803427FGP
CSB-MP803427FGP
CSB-EP803427FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato N utilization substance protein B homolog (nusB) CSB-YP803428FGP
CSB-EP803428FGP
CSB-BP803428FGP
CSB-MP803428FGP
CSB-EP803428FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 30S ribosomal protein S11 (rpsK) CSB-YP803429FGP
CSB-EP803429FGP
CSB-BP803429FGP
CSB-MP803429FGP
CSB-EP803429FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 30S ribosomal protein S8 (rpsH) CSB-YP803430FGP
CSB-EP803430FGP
CSB-BP803430FGP
CSB-MP803430FGP
CSB-EP803430FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 30S ribosomal protein S3 (rpsC) CSB-YP803431FGP
CSB-EP803431FGP
CSB-BP803431FGP
CSB-MP803431FGP
CSB-EP803431FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato 50S ribosomal protein L3 (rplC) CSB-YP803432FGP
CSB-EP803432FGP
CSB-BP803432FGP
CSB-MP803432FGP
CSB-EP803432FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP803433FGP
CSB-EP803433FGP
CSB-BP803433FGP
CSB-MP803433FGP
CSB-EP803433FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas syringae pv. tomato Tyrosine--tRNA ligase (tyrS) CSB-YP803434FGP
CSB-EP803434FGP
CSB-BP803434FGP
CSB-MP803434FGP
CSB-EP803434FGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>